Fluorouracil Injection

Generic name: Pronounced as (floor'' oh ure' a sil)
Brand names
  • Adrucil® Injection
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 07/18/2012

Fluorouracil injection should be given in a hospital or medical facility under the supervision of a doctor who is experienced in giving chemotherapy medications for cancer. Treatment with fluorouracil injection may cause serious side effects.

Fluorouracil is generally used in combination with other medications to treat colon cancer or rectal cancer (cancer that begins in the large intestine) that has gotten worse or spread to other parts of the body. Fluorouracil is used in combination with other medications to treat certain types of breast cancer after surgery to remove the tumor or radiation therapy. Fluorouracil is also used to treat cancer of the pancreas and stomach cancer. Fluorouracil is in a class of medications called antimetabolites. It works by slowing or stopping the growth of cancer cells in your body.

Fluorouracil injection comes as a solution (liquid) to be given intravenously (into a vein) by a doctor or nurse in a medical facility. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have.

Your doctor may need to delay your treatment or change your dose if you experience certain side effects. It is important for you to tell your doctor how you are feeling during your treatment with fluorouracil injection.

Fluorouracil is also sometimes used to treat cancer of the cervix (opening of the uterus) and esophagus, head and neck cancer (including cancer of the mouth, lip, cheek, tongue, palate, throat, tonsils, and sinuses), ovarian cancer (cancer that begins in the female reproductive organs where eggs are formed), and renal cell cancer (RCC, a type of cancer that begins in the kidney). Talk to your doctor about the risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before receiving fluorouracil,

  • tell your doctor and pharmacist if you are allergic to fluorouracil or any of the ingredients in fluorouracil injection. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: certain chemotherapy medications such as bendamustine (Treanda), busulfan (Myerlan, Busulfex), carmustine (BiCNU, Gliadel Wafer), cyclophosphamide (Cytoxan), chlorambucil (Leukeran), ifosfamide (Ifex), lomustine (CeeNU), melphalan (Alkeran), procarbazine (Mutalane), or temozolomide (Temodar); medications that suppress the immune system such as azathioprine (Imuran), cyclosporine (Neoral, Sandimmune), methotrexate (Rheumatrex), sirolimus (Rapamune), and tacrolimus (Prograf). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have an infection. Your doctor may not want you to receive fluorouracil injection.

  • tell your doctor if you have previously received radiation (x-ray) therapy or treatment with other chemotherapy medications or if you have or have ever had kidney or liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. You should not become pregnant or breast-feed while you are receiving fluorouracil injection. If you become pregnant while receiving fluorouracil injection, call your doctor. Fluorouracil may harm the fetus.

  • plan to avoid unnecessary or prolonged exposure to sunlight and to wear protective clothing, sunglasses, and sunscreen. Fluorouracil may make your skin sensitive to sunlight.

Unless your doctor tells you otherwise, continue your normal diet.

  • Fluorouracil may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • loss of appetite

    • nausea

    • unusual tiredness or weakness

    • dizziness

    • headache

    • hair loss

    • dry and cracked skin

    • vision changes

    • eye that are teary or sensitive to light

    • redness, pain, swelling, or burning at the site where the injection was given

    • confusion

  • Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:

    • sores in the mouth and throat

    • diarrhea

    • vomiting

    • swelling, pain, redness, or peeling of skin on the palms and soles of the feet

    • fever, chills, sore throat, or other signs of an infection

    • hives

    • rash

    • itching

    • difficulty breathing or swallowing

    • nosebleeds

    • coughing up or vomiting blood or material that looks like coffee grounds

    • unusual bleeding or bruising

    • pink, red, or dark brown urine

    • red or tarry black bowel movements

    • chest pain

  • Fluorouracil may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • nausea

  • diarrhea

  • vomiting

  • fever, chills, sore throat, or other signs of an infection

  • unusual bleeding or bruising

  • bloody or black, tarry stools

  • coughing up or vomiting blood or material that looks like coffee grounds

Keep all appointments with your doctor and the laboratory.Your doctor will/may order certain lab tests to check your body's response to fluorouracil.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • 5-Fluorouracil
  • 5-FU

Drug Interaction
Moxifloxacin Moxifloxacin The metabolism of Fluorouracil can be decreased when combined with Moxifloxacin.
Repaglinide Repaglinide The metabolism of Repaglinide can be decreased when combined with Fluorouracil.
Montelukast Montelukast The metabolism of Fluorouracil can be decreased when combined with Montelukast.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The metabolism of Fluorouracil can be increased when combined with Insulin glargine.
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Leflunomide is combined with Fluorouracil.
Nevirapine Nevirapine The metabolism of Fluorouracil can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Fluorouracil.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Dolasetron.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Fluorouracil.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Anagrelide.
Candesartan Candesartan The metabolism of Fluorouracil can be decreased when combined with Candesartan.
Cilostazol Cilostazol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Fluorouracil.
Clopidogrel Clopidogrel The metabolism of Fluorouracil can be decreased when combined with Clopidogrel.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Fluorouracil.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Fluorouracil can be decreased when combined with Conjugated estrogens.
Fenofibrate Fenofibrate The metabolism of Fluorouracil can be decreased when combined with Fenofibrate.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Fluorouracil is combined with Mycophenolic acid.
Paregoric Paregoric The metabolism of Fluorouracil can be decreased when combined with Morphine.
Penbutolol Penbutolol The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Acebutolol.
Prednisone Prednisone The metabolism of Prednisone can be increased when combined with Fluorouracil.
Ranitidine Ranitidine The metabolism of Ranitidine can be decreased when combined with Fluorouracil.
Tacrolimus Tacrolimus Tacrolimus may increase the immunosuppressive activities of Fluorouracil.
Tizanidine Tizanidine The metabolism of Fluorouracil can be decreased when combined with Tizanidine.
Triamcinolone Triamcinolone The risk or severity of adverse effects can be increased when Fluorouracil is combined with Triamcinolone.
Zolmitriptan Zolmitriptan The metabolism of Fluorouracil can be decreased when combined with Zolmitriptan.
Famotidine Injection Famotidine Injection The metabolism of Fluorouracil can be decreased when combined with Famotidine.
Fluconazole Injection Fluconazole Injection The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Fluorouracil.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Fluorouracil.
Hydromorphone Injection Hydromorphone Injection The metabolism of Hydromorphone can be decreased when combined with Fluorouracil.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Fluorouracil.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluorouracil.
Levofloxacin Injection Levofloxacin Injection The metabolism of Levofloxacin can be decreased when combined with Fluorouracil.
Meperidine Injection Meperidine Injection The metabolism of Fluorouracil can be increased when combined with Meperidine.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Methylprednisolone.
Metoclopramide Injection Metoclopramide Injection The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Fluorouracil.
Metronidazole Injection Metronidazole Injection The serum concentration of Fluorouracil can be increased when it is combined with Metronidazole.
Morphine Injection Morphine Injection The metabolism of Fluorouracil can be decreased when combined with Morphine.
Zidovudine Injection Zidovudine Injection The metabolism of Fluorouracil can be decreased when combined with Zidovudine.
Altretamine Altretamine The metabolism of Fluorouracil can be decreased when combined with Amphetamine.
Cyclosporine Cyclosporine Fluorouracil may increase the immunosuppressive activities of Cyclosporine.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Fluorouracil.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Fluorouracil.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Granisetron.
Torsemide Torsemide The metabolism of Fluorouracil can be decreased when combined with Torasemide.
Olanzapine Olanzapine The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Fluorouracil.
Alosetron Alosetron The metabolism of Fluorouracil can be decreased when combined with Alosetron.
Dofetilide Dofetilide The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Dofetilide.
Hydroxychloroquine Hydroxychloroquine The metabolism of Hydroxychloroquine can be decreased when combined with Fluorouracil.
Meloxicam Meloxicam The metabolism of Meloxicam can be decreased when combined with Fluorouracil.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Telmisartan Telmisartan Telmisartan may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Fluorouracil is combined with Temozolomide.
Anakinra Anakinra The metabolism of Fluorouracil can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Desloratadine.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Fluorouracil is combined with Linezolid.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Fluorouracil.
Trimipramine Trimipramine The metabolism of Fluorouracil can be decreased when combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Fluorouracil can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Fluorouracil can be increased when combined with Modafinil.
Sirolimus Sirolimus The risk or severity of adverse effects can be increased when Fluorouracil is combined with Sirolimus.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Fluorouracil.
Escitalopram Escitalopram The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Escitalopram.
Zonisamide Zonisamide The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Fluorouracil.
Adalimumab Injection Adalimumab Injection The metabolism of Fluorouracil can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Fluorouracil.
Atomoxetine Atomoxetine The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Fluorouracil.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Glatiramer.
Atazanavir Atazanavir The metabolism of Fluorouracil can be decreased when combined with Atazanavir.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Fluorouracil.
Eletriptan Eletriptan The metabolism of Fluorouracil can be increased when combined with Eletriptan.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Fluorouracil.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Fluorouracil.
Vardenafil Vardenafil The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Fluorouracil.
Alfuzosin Alfuzosin The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Fluorouracil.
Interferon Beta-1a Subcutaneous Injection Interferon Beta-1a Subcutaneous Injection The metabolism of Fluorouracil can be decreased when combined with Interferon beta-1a.
Memantine Memantine The metabolism of Fluorouracil can be decreased when combined with Memantine.
Tegaserod Tegaserod The metabolism of Fluorouracil can be decreased when combined with Tegaserod.
Frovatriptan Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Fluorouracil.
Gemifloxacin Gemifloxacin The metabolism of Gemifloxacin can be decreased when combined with Fluorouracil.
Progesterone Progesterone The metabolism of Fluorouracil can be increased when combined with Progesterone.
Apomorphine Injection Apomorphine Injection The metabolism of Fluorouracil can be decreased when combined with Apomorphine.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Fluorouracil.
Infliximab Injection Infliximab Injection The metabolism of Fluorouracil can be increased when combined with Infliximab.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Fluorouracil.
Rifaximin Rifaximin The metabolism of Fluorouracil can be increased when combined with Rifaximin.
Duloxetine Duloxetine The metabolism of Fluorouracil can be decreased when combined with Duloxetine.
Bosentan Bosentan The metabolism of Bosentan can be decreased when combined with Fluorouracil.
Cinacalcet Cinacalcet The metabolism of Cinacalcet can be decreased when combined with Fluorouracil.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Natalizumab.
Erlotinib Erlotinib The metabolism of Fluorouracil can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone The metabolism of Fluorouracil can be decreased when combined with Eszopiclone.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Fluorouracil.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Fluorouracil.
Voriconazole Voriconazole The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Fluorouracil.
Dextroamphetamine Dextroamphetamine The metabolism of Fluorouracil can be decreased when combined with Amphetamine.
Entecavir Entecavir The metabolism of Fluorouracil can be decreased when combined with Entecavir.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluorouracil.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Fluorouracil can be increased when it is combined with Peginterferon alfa-2b.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Fluorouracil.
Ramelteon Ramelteon The metabolism of Ramelteon can be decreased when combined with Fluorouracil.
Pregabalin Pregabalin The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Fluorouracil.
Deferasirox Deferasirox The serum concentration of Fluorouracil can be increased when it is combined with Deferasirox.
Phenylephrine Phenylephrine The metabolism of Fluorouracil can be increased when combined with Phenylephrine.
Felbamate Felbamate The risk or severity of QTc prolongation can be increased when Felbamate is combined with Fluorouracil.
Ranolazine Ranolazine The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Fluorouracil.
Abatacept Injection Abatacept Injection The metabolism of Fluorouracil can be increased when combined with Abatacept.
Rasagiline Rasagiline The metabolism of Rasagiline can be decreased when combined with Fluorouracil.
Imatinib Imatinib The metabolism of Imatinib can be decreased when combined with Fluorouracil.
Sitagliptin Sitagliptin The metabolism of Sitagliptin can be decreased when combined with Fluorouracil.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Fluorouracil.
Gefitinib Gefitinib Gefitinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Fluorouracil.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Paliperidone.
Bortezomib Bortezomib The risk or severity of adverse effects can be increased when Bortezomib is combined with Fluorouracil.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Clofarabine.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Fluorouracil.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Fluorouracil.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Fluorouracil.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Fluorouracil.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The metabolism of Fluorouracil can be increased when combined with Insulin glulisine.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Fluorouracil.
Posaconazole Posaconazole The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Fluorouracil.
Primaquine Primaquine The metabolism of Primaquine can be increased when combined with Fluorouracil.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Fluorouracil.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Pemetrexed.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Dimenhydrinate.
Nabilone Nabilone The metabolism of Fluorouracil can be decreased when combined with Nabilone.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Fluorouracil is combined with Vorinostat.
Sorafenib Sorafenib The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Fluorouracil.
Sunitinib Sunitinib The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Sunitinib.
Dronabinol Dronabinol Dronabinol may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Lapatinib Lapatinib The metabolism of Fluorouracil can be decreased when combined with Lapatinib.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Fluorouracil.
Dasatinib Dasatinib The risk or severity of adverse effects can be increased when Fluorouracil is combined with Dasatinib.
Mexiletine Mexiletine The metabolism of Fluorouracil can be decreased when combined with Mexiletine.
Armodafinil Armodafinil The metabolism of Fluorouracil can be increased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Azacitidine.
Temsirolimus Temsirolimus The risk or severity of adverse effects can be increased when Fluorouracil is combined with Temsirolimus.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Fluorouracil.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Fluorouracil.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Toremifene.
Bexarotene Bexarotene The metabolism of Fluorouracil can be decreased when combined with Bexarotene.
Budesonide Budesonide The risk or severity of adverse effects can be increased when Fluorouracil is combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluorouracil.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Decitabine.
Etravirine Etravirine The metabolism of Etravirine can be decreased when combined with Fluorouracil.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Mitoxantrone.
Tretinoin Tretinoin The metabolism of Tretinoin can be decreased when combined with Fluorouracil.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Bendamustine.
Leucovorin Injection Leucovorin Injection The risk or severity of adverse effects can be increased when Leucovorin is combined with Fluorouracil.
Pilocarpine Pilocarpine The metabolism of Fluorouracil can be decreased when combined with Pilocarpine.
Flecainide Flecainide The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Fluorouracil can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Irinotecan.
Levoleucovorin Injection Levoleucovorin Injection The risk or severity of adverse effects can be increased when Levoleucovorin is combined with Fluorouracil.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Fluorouracil is combined with Estramustine.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Fluorouracil.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Fluorouracil.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Fluorouracil.
Eltrombopag Eltrombopag The metabolism of Fluorouracil can be decreased when combined with Eltrombopag.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Fluorouracil.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Fluorouracil.
Betaxolol Betaxolol The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Fluorouracil.
Iloperidone Iloperidone The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Iloperidone.
Prasugrel Prasugrel The metabolism of Prasugrel can be decreased when combined with Fluorouracil.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Fluorouracil.
Everolimus Everolimus The risk or severity of adverse effects can be increased when Fluorouracil is combined with Everolimus.
Dronedarone Dronedarone The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Pralatrexate.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Romidepsin.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Fluorouracil.
Topotecan Topotecan The risk or severity of adverse effects can be increased when Fluorouracil is combined with Topotecan.
Golimumab Injection Golimumab Injection The metabolism of Fluorouracil can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Fluorouracil.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Asenapine.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Fluorouracil.
Albendazole Albendazole The metabolism of Fluorouracil can be decreased when combined with Albendazole.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Fluorouracil.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Fluorouracil.
Tocilizumab Injection Tocilizumab Injection The metabolism of Fluorouracil can be increased when combined with Tocilizumab.
Fingolimod Fingolimod Fluorouracil may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Fluorouracil.
Lurasidone Lurasidone The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Fluorouracil.
Acetaminophen Injection Acetaminophen Injection The metabolism of Fluorouracil can be decreased when combined with Acetaminophen.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluorouracil.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Fluorouracil.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Fluorouracil.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Belimumab.
Busulfan Injection Busulfan Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Busulfan.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Fluorouracil.
Rilpivirine Rilpivirine Rilpivirine may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Telaprevir Telaprevir Glecaprevir may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Fluorouracil can be increased when combined with Cyclophosphamide.
Abiraterone Abiraterone The serum concentration of Fluorouracil can be increased when it is combined with Abiraterone.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Fluorouracil.
Rivaroxaban Rivaroxaban The risk or severity of bleeding can be increased when Rivaroxaban is combined with Fluorouracil.
Ticagrelor Ticagrelor The risk or severity of bleeding can be increased when Ticagrelor is combined with Fluorouracil.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Brentuximab vedotin.
Ruxolitinib Ruxolitinib The risk or severity of adverse effects can be increased when Fluorouracil is combined with Ruxolitinib.
Vandetanib Vandetanib The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Vandetanib.
Vemurafenib Vemurafenib The serum concentration of Fluorouracil can be increased when it is combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Fluorouracil can be decreased when combined with Vismodegib.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Belatacept.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Fluorouracil.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Fluorouracil.
Crizotinib Crizotinib The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Crizotinib.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Melphalan.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding can be increased when Fondaparinux is combined with Fluorouracil.
Pertuzumab Injection Pertuzumab Injection The risk or severity of cardiotoxicity can be increased when Fluorouracil is combined with Pertuzumab.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Carfilzomib.
Iloprost Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Fluorouracil.
Enzalutamide Enzalutamide The metabolism of Fluorouracil can be decreased when combined with Enzalutamide.
Mirabegron Mirabegron The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Fluorouracil.
Regorafenib Regorafenib The metabolism of Fluorouracil can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Bosutinib can be decreased when combined with Fluorouracil.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Corticotropin.
Teriflunomide Teriflunomide The serum concentration of Fluorouracil can be decreased when it is combined with Teriflunomide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Fluorouracil.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Bedaquiline.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Fluorouracil.
Tofacitinib Tofacitinib Fluorouracil may increase the immunosuppressive activities of Tofacitinib.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Fluorouracil is combined with Dimethyl fumarate.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Fluorouracil.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Fluorouracil is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Trastuzumab emtansine.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Fluorouracil.
Dabrafenib Dabrafenib The metabolism of Fluorouracil can be decreased when combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Fluorouracil.
Trametinib Trametinib The metabolism of Fluorouracil can be decreased when combined with Trametinib.
Afatinib Afatinib Afatinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Fluorouracil.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Fluorouracil.
Perampanel Perampanel The metabolism of Perampanel can be decreased when combined with Fluorouracil.
Ibrutinib Ibrutinib The risk or severity of adverse effects can be increased when Fluorouracil is combined with Ibrutinib.
Ketorolac Injection Ketorolac Injection The metabolism of Fluorouracil can be decreased when combined with Ketorolac.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Obinutuzumab.
Simeprevir Simeprevir The metabolism of Fluorouracil can be decreased when combined with Simeprevir.
Dapagliflozin Dapagliflozin The metabolism of Fluorouracil can be decreased when combined with Dapagliflozin.
Apremilast Apremilast The metabolism of Fluorouracil can be increased when combined with Apremilast.
Ceritinib Ceritinib The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Fluorouracil can be increased when combined with Siltuximab.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Belinostat.
Idelalisib Idelalisib The risk or severity of adverse effects can be increased when Fluorouracil is combined with Idelalisib.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be decreased when combined with Fluorouracil.
Vorapaxar Vorapaxar The risk or severity of bleeding can be increased when Vorapaxar is combined with Fluorouracil.
Edoxaban Edoxaban The risk or severity of bleeding can be increased when Edoxaban is combined with Fluorouracil.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Peginterferon beta-1a.
Olaparib Olaparib The risk or severity of adverse effects can be increased when Fluorouracil is combined with Olaparib.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Blinatumomab.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Fluorouracil.
Riociguat Riociguat The metabolism of Riociguat can be decreased when combined with Fluorouracil.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Fluorouracil is combined with Pirfenidone.
Secukinumab Injection Secukinumab Injection The metabolism of Fluorouracil can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of QTc prolongation can be increased when Risperidone is combined with Fluorouracil.
Palbociclib Palbociclib The risk or severity of adverse effects can be increased when Fluorouracil is combined with Palbociclib.
Insulin Human Inhalation Insulin Human Inhalation The metabolism of Fluorouracil can be increased when combined with Insulin human.
Lenvatinib Lenvatinib The metabolism of Fluorouracil can be decreased when combined with Lenvatinib.
Panobinostat Panobinostat The risk or severity of adverse effects can be increased when Fluorouracil is combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Fluorouracil.
Ivabradine Ivabradine Ivabradine may increase the QTc-prolonging activities of Fluorouracil.
Rolapitant Rolapitant Rolapitant may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Prednisolone Prednisolone The risk or severity of adverse effects can be increased when Fluorouracil is combined with Prednisolone.
Daclatasvir Daclatasvir Daclatasvir may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Ziprasidone.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The metabolism of Fluorouracil can be increased when combined with Insulin degludec.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Fluorouracil.
Osimertinib Osimertinib The serum concentration of Fluorouracil can be decreased when it is combined with Osimertinib.
Alectinib Alectinib Alectinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Rifapentine Rifapentine The metabolism of Fluorouracil can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Lesinurad can be decreased when combined with Fluorouracil.
Dexamethasone Injection Dexamethasone Injection The metabolism of Dexamethasone can be increased when combined with Fluorouracil.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Fluorouracil.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Fluorouracil.
Venetoclax Venetoclax Venetoclax may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Cobicistat Cobicistat Cobicistat may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Selexipag Selexipag The metabolism of Selexipag can be decreased when combined with Fluorouracil.
Obeticholic Acid Obeticholic Acid The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Fluorouracil.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Fluorouracil.
Furosemide Injection Furosemide Injection The therapeutic efficacy of Furosemide can be decreased when used in combination with Fluorouracil.
Rucaparib Rucaparib The metabolism of Fluorouracil can be decreased when combined with Rucaparib.
Ribociclib Ribociclib The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Ribociclib.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Brodalumab.
Brigatinib Brigatinib The metabolism of Fluorouracil can be decreased when combined with Brigatinib.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Fluorouracil.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Deutetrabenazine.
Deflazacort Deflazacort The risk or severity of adverse effects can be increased when Fluorouracil is combined with Deflazacort.
Safinamide Safinamide The metabolism of Fluorouracil can be decreased when combined with Safinamide.
Ocrelizumab Injection Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Fluorouracil.
Sarilumab Injection Sarilumab Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Fluorouracil can be decreased when combined with Midostaurin.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Guselkumab.
Enasidenib Enasidenib The metabolism of Fluorouracil can be decreased when combined with Enasidenib.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Fluorouracil.
Abemaciclib Abemaciclib Abemaciclib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Betrixaban Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Fluorouracil.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fluorouracil.
Letermovir Letermovir The metabolism of Fluorouracil can be decreased when combined with Letermovir.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Tetrabenazine.
Buprenorphine Injection Buprenorphine Injection The metabolism of Fluorouracil can be decreased when combined with Buprenorphine.
Apalutamide Apalutamide The metabolism of Apalutamide can be decreased when combined with Fluorouracil.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Fluorouracil is combined with Penicillamine.
Fostamatinib Fostamatinib Fostamatinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Avatrombopag Avatrombopag The metabolism of Fluorouracil can be increased when combined with Avatrombopag.
Baricitinib Baricitinib The risk or severity of adverse effects can be increased when Fluorouracil is combined with Baricitinib.
Lofexidine Lofexidine The metabolism of Lofexidine can be decreased when combined with Fluorouracil.
Eliglustat Eliglustat The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Eliglustat.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Encorafenib.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Fluorouracil.
Ivosidenib Ivosidenib The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Ivosidenib.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Fluorouracil.
Cannabidiol Cannabidiol The metabolism of Fluorouracil can be decreased when combined with Cannabidiol.
Dacomitinib Dacomitinib The metabolism of Fluorouracil can be decreased when combined with Dacomitinib.
Stiripentol Stiripentol The metabolism of Fluorouracil can be decreased when combined with Stiripentol.
Gilteritinib Gilteritinib Gilteritinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Glasdegib Glasdegib The metabolism of Glasdegib can be decreased when combined with Fluorouracil.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Fluorouracil.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Fluorouracil.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Fluorouracil.
Rifamycin Rifamycin The metabolism of Fluorouracil can be decreased when combined with Rifamycin.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Fluorouracil can be increased when combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Fluorouracil.
Acyclovir Ophthalmic Acyclovir Ophthalmic The metabolism of Acyclovir can be decreased when combined with Fluorouracil.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Fluorouracil.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Fluorouracil.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Risankizumab.
Alpelisib Alpelisib The metabolism of Fluorouracil can be decreased when combined with Alpelisib.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Fluorouracil.
Darolutamide Darolutamide The serum concentration of Fluorouracil can be increased when it is combined with Darolutamide.
Triclabendazole Triclabendazole The metabolism of Fluorouracil can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Entrectinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Fluorouracil.
Pitolisant Pitolisant Fluorouracil may increase the QTc-prolonging activities of Pitolisant.
Fedratinib Fedratinib Fedratinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Lefamulin Lefamulin Lefamulin may increase the QTc-prolonging activities of Fluorouracil.
Phenytoin Injection Phenytoin Injection The serum concentration of Phenytoin can be increased when it is combined with Fluorouracil.
Fosphenytoin Injection Fosphenytoin Injection The serum concentration of Fosphenytoin can be increased when it is combined with Fluorouracil.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Fluorouracil.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Fluorouracil.
Lasmiditan Lasmiditan The serum concentration of Fluorouracil can be increased when it is combined with Lasmiditan.
Cenobamate Cenobamate The metabolism of Cenobamate can be increased when combined with Fluorouracil.
Ozanimod Ozanimod The metabolism of Ozanimod can be decreased when combined with Fluorouracil.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Fluorouracil.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Fluorouracil.
Ripretinib Ripretinib Ripretinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Selpercatinib Selpercatinib The serum concentration of Fluorouracil can be increased when it is combined with Selpercatinib.
Capmatinib Capmatinib The serum concentration of Fluorouracil can be increased when it is combined with Capmatinib.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Fluorouracil.
Octreotide Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Fluorouracil.
Pralsetinib Pralsetinib The metabolism of Fluorouracil can be decreased when combined with Pralsetinib.
Opicapone Opicapone The metabolism of Fluorouracil can be decreased when combined with Opicapone.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Fluorouracil can be decreased when it is combined with Satralizumab.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Relugolix is combined with Fluorouracil.
Viloxazine Viloxazine The metabolism of Fluorouracil can be decreased when combined with Viloxazine.
Theophylline Theophylline The metabolism of Fluorouracil can be decreased when combined with Theophylline.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Fluorouracil.
Mefenamic Acid Mefenamic Acid The metabolism of Fluorouracil can be decreased when combined with Mefenamic acid.
Naproxen Naproxen The metabolism of Naproxen can be decreased when combined with Fluorouracil.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Fluorouracil.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Fluorouracil is combined with Hydroxyurea.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Fluorouracil.
Phenobarbital Phenobarbital The metabolism of Fluorouracil can be increased when combined with Phenobarbital.
Methotrexate Injection Methotrexate Injection The risk or severity of adverse effects can be increased when Methotrexate is combined with Fluorouracil.
Primidone Primidone The metabolism of Primidone can be increased when combined with Fluorouracil.
Methsuximide Methsuximide The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Fluorouracil.
Chlorpromazine Chlorpromazine The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Fluorouracil.
Diazepam Diazepam The metabolism of Diazepam can be decreased when combined with Fluorouracil.
Flurazepam Flurazepam The metabolism of Flurazepam can be decreased when combined with Fluorouracil.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Fluorouracil.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Fluorouracil.
Tranylcypromine Tranylcypromine The metabolism of Fluorouracil can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Fluorouracil can be decreased when combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Fluorouracil is combined with Procarbazine.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Fluorouracil.
Prochlorperazine Prochlorperazine The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Fluorouracil.
Thioridazine Thioridazine The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Thioridazine.
Trifluoperazine Trifluoperazine The metabolism of Trifluoperazine can be decreased when combined with Fluorouracil.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Fluorouracil.
Dapsone Dapsone The metabolism of Fluorouracil can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The metabolism of Fluorouracil can be decreased when combined with Sulfadiazine.
Methadone Methadone The metabolism of Fluorouracil can be decreased when combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Fluorouracil can be decreased when combined with Oxybutynin.
Benztropine Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Fluorouracil.
Maprotiline Maprotiline The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Fluorouracil.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Fluorouracil.
Orphenadrine Orphenadrine The metabolism of Fluorouracil can be decreased when combined with Orphenadrine.
Perphenazine Perphenazine The metabolism of Perphenazine can be decreased when combined with Fluorouracil.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Fluorouracil is combined with Azathioprine.
Amoxapine Amoxapine The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Fluorouracil.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Fluorouracil is combined with Sulfasalazine.
Hydrocortisone Hydrocortisone The metabolism of Fluorouracil can be increased when combined with Hydrocortisone.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Fluorouracil is combined with Lomustine.
Doxorubicin Doxorubicin The risk or severity of adverse effects can be increased when Fluorouracil is combined with Doxorubicin.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Fluorouracil is combined with Cytarabine.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Fluorouracil is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Fluorouracil is combined with Dactinomycin.
Carbamazepine Carbamazepine The risk or severity of adverse effects can be increased when Fluorouracil is combined with Carbamazepine.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Fluorouracil.
Cimetidine Cimetidine The serum concentration of Fluorouracil can be increased when it is combined with Cimetidine.
Warfarin Warfarin The metabolism of Fluorouracil can be decreased when combined with Warfarin.
Loperamide Loperamide The metabolism of Loperamide can be decreased when combined with Fluorouracil.
Promethazine Promethazine The risk or severity of QTc prolongation can be increased when Promethazine is combined with Fluorouracil.
Meclofenamate Meclofenamate The therapeutic efficacy of Meclofenamic acid can be decreased when used in combination with Fluorouracil.
Daunorubicin Daunorubicin The risk or severity of adverse effects can be increased when Fluorouracil is combined with Daunorubicin.
Nitrofurantoin Nitrofurantoin The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Fluorouracil.
Griseofulvin Griseofulvin The metabolism of Fluorouracil can be increased when combined with Griseofulvin.
Digoxin Digoxin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Fluorouracil.
Chloroquine Chloroquine The metabolism of Chloroquine can be decreased when combined with Fluorouracil.
Quinine Quinine The metabolism of Quinine can be decreased when combined with Fluorouracil.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Fluorouracil.
Triamterene Triamterene The metabolism of Fluorouracil can be decreased when combined with Triamterene.
Sulfinpyrazone Sulfinpyrazone The metabolism of Fluorouracil can be decreased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Fluorouracil.
Secobarbital Secobarbital The metabolism of Fluorouracil can be increased when combined with Secobarbital.
Desipramine Desipramine The risk or severity of QTc prolongation can be increased when Desipramine is combined with Fluorouracil.
Amitriptyline Amitriptyline The metabolism of Fluorouracil can be decreased when combined with Amitriptyline.
Imipramine Imipramine The metabolism of Fluorouracil can be decreased when combined with Imipramine.
Probenecid Probenecid The metabolism of Fluorouracil can be increased when combined with Probenecid.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Fluorouracil.
Procainamide Procainamide The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Procainamide.
Isoniazid Isoniazid The metabolism of Fluorouracil can be decreased when combined with Isoniazid.
Rifampin Rifampin The metabolism of Fluorouracil can be decreased when combined with Rifampicin.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Disopyramide.
Valproic Acid Valproic Acid The metabolism of Valproic acid can be decreased when combined with Fluorouracil.
Tamoxifen Tamoxifen The metabolism of Fluorouracil can be decreased when combined with Tamoxifen.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Fluorouracil.
Levothyroxine Levothyroxine The metabolism of Fluorouracil can be decreased when combined with Levothyroxine.
Liothyronine Liothyronine The therapeutic efficacy of Liothyronine can be decreased when used in combination with Fluorouracil.
Methimazole Methimazole The metabolism of Methimazole can be decreased when combined with Fluorouracil.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Fluorouracil is combined with Propylthiouracil.
Chlorpropamide Chlorpropamide The metabolism of Chlorpropamide can be decreased when combined with Fluorouracil.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Fluorouracil.
Tolazamide Tolazamide The metabolism of Tolazamide can be decreased when combined with Fluorouracil.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Fluorouracil.
Cyclobenzaprine Cyclobenzaprine The metabolism of Cyclobenzaprine can be decreased when combined with Fluorouracil.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Fluorouracil.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Fluorouracil.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Fluorouracil.
Methyclothiazide Methyclothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Fluorouracil.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Fluorouracil.
Dantrolene Dantrolene The therapeutic efficacy of Dantrolene can be decreased when used in combination with Fluorouracil.
Chlorzoxazone Chlorzoxazone The metabolism of Fluorouracil can be decreased when combined with Chlorzoxazone.
Folic Acid Folic Acid The risk or severity of adverse effects can be increased when Folic acid is combined with Fluorouracil.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Fluorouracil.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Propranolol.
Nortriptyline Nortriptyline The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Fluorouracil.
Spironolactone Spironolactone The metabolism of Fluorouracil can be decreased when combined with Spironolactone.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Fluorouracil is combined with Mercaptopurine.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Fluorouracil.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Fluorouracil.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Papaverine.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Fluorouracil.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Fluorouracil is combined with Dacarbazine.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Fluorouracil.
Ketoconazole Ketoconazole The metabolism of Fluorouracil can be decreased when combined with Ketoconazole.
Thiotepa Injection Thiotepa Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Thiotepa.
Vincristine Injection Vincristine Injection The risk or severity of adverse effects can be increased when Vincristine is combined with Fluorouracil.
Dipyridamole Dipyridamole The risk or severity of bleeding can be increased when Dipyridamole is combined with Fluorouracil.
Vinblastine Vinblastine The risk or severity of adverse effects can be increased when Fluorouracil is combined with Vinblastine.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Fluorouracil.
Thiothixene Thiothixene The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Fluorouracil.
Aspirin Aspirin The metabolism of Acetylsalicylic acid can be decreased when combined with Fluorouracil.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Fluorouracil.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Fluorouracil.
Trimethoprim Trimethoprim The metabolism of Trimethoprim can be decreased when combined with Fluorouracil.
Diltiazem Diltiazem The metabolism of Fluorouracil can be decreased when combined with Diltiazem.
Nifedipine Nifedipine The metabolism of Fluorouracil can be decreased when combined with Nifedipine.
Timolol Timolol The risk or severity of QTc prolongation can be increased when Timolol is combined with Fluorouracil.
Verapamil Verapamil The metabolism of Fluorouracil can be decreased when combined with Verapamil.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Fluorouracil.
Piroxicam Piroxicam The metabolism of Fluorouracil can be decreased when combined with Piroxicam.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Fluorouracil.
Etoposide Etoposide The risk or severity of adverse effects can be increased when Fluorouracil is combined with Etoposide.
Glyburide Glyburide The metabolism of Glyburide can be decreased when combined with Fluorouracil.
Glipizide Glipizide The metabolism of Glipizide can be decreased when combined with Fluorouracil.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Indapamide is combined with Fluorouracil.
Nafcillin Injection Nafcillin Injection The metabolism of Fluorouracil can be increased when combined with Nafcillin.
Pentoxifylline Pentoxifylline The metabolism of Pentoxifylline can be decreased when combined with Fluorouracil.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Pentamidine.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Fluorouracil.
Gemfibrozil Gemfibrozil The metabolism of Fluorouracil can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz The metabolism of Guanabenz can be decreased when combined with Fluorouracil.
Ketoprofen Ketoprofen The metabolism of Ketoprofen can be decreased when combined with Fluorouracil.
Pimozide Pimozide The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Pimozide.
Flurbiprofen Flurbiprofen The metabolism of Flurbiprofen can be decreased when combined with Fluorouracil.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Fluorouracil.
Lovastatin Lovastatin The metabolism of Fluorouracil can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The metabolism of Fluorouracil can be decreased when combined with Ciprofloxacin.
Diclofenac Diclofenac The metabolism of Diclofenac can be decreased when combined with Fluorouracil.
Fluoxetine Fluoxetine The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Fluorouracil.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Fluorouracil.
Clozapine Clozapine The risk or severity of neutropenia can be increased when Fluorouracil is combined with Clozapine.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Fluorouracil is combined with Idarubicin.
Ofloxacin Ofloxacin The metabolism of Ofloxacin can be decreased when combined with Fluorouracil.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Pentostatin.
Clarithromycin Clarithromycin The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Clarithromycin.
Etodolac Etodolac The metabolism of Etodolac can be decreased when combined with Fluorouracil.
Felodipine Felodipine The metabolism of Fluorouracil can be decreased when combined with Felodipine.
Nabumetone Nabumetone The metabolism of Fluorouracil can be decreased when combined with Nabumetone.
Pravastatin Pravastatin Pravastatin may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Simvastatin Simvastatin The metabolism of Fluorouracil can be decreased when combined with Simvastatin.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fluorouracil.
Teniposide Injection Teniposide Injection The risk or severity of adverse effects can be increased when Teniposide is combined with Fluorouracil.
Itraconazole Itraconazole The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Fluorouracil.
Rifabutin Rifabutin The metabolism of Fluorouracil can be increased when combined with Rifabutin.
Sotalol Sotalol The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Sotalol.
Zolpidem Zolpidem The metabolism of Fluorouracil can be decreased when combined with Zolpidem.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Fluorouracil.
Isradipine Isradipine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Fluorouracil.
Omeprazole Omeprazole The metabolism of Fluorouracil can be decreased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Cisapride can be decreased when combined with Fluorouracil.
Fluvastatin Fluvastatin The metabolism of Fluorouracil can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Fluorouracil.
Fluvoxamine Fluvoxamine The metabolism of Fluorouracil can be decreased when combined with Fluvoxamine.
Lamotrigine Lamotrigine The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Fluorouracil.
Losartan Losartan The metabolism of Losartan can be decreased when combined with Fluorouracil.
Vinorelbine Injection Vinorelbine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Fluorouracil.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Carboplatin.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Fluorouracil.
Lansoprazole Lansoprazole The metabolism of Fluorouracil can be decreased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be increased when combined with Fluorouracil.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Fluorouracil.
Nicardipine Nicardipine The metabolism of Fluorouracil can be decreased when combined with Nicardipine.
Bupropion Bupropion The metabolism of Bupropion can be decreased when combined with Fluorouracil.
Ticlopidine Ticlopidine The metabolism of Fluorouracil can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Fluorouracil can be decreased when combined with Saquinavir.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Fluorouracil.
Riluzole Riluzole The metabolism of Riluzole can be decreased when combined with Fluorouracil.
Glimepiride Glimepiride The metabolism of Glimepiride can be decreased when combined with Fluorouracil.
Anastrozole Anastrozole The metabolism of Anastrozole can be decreased when combined with Fluorouracil.
Gemcitabine Injection Gemcitabine Injection The serum concentration of Fluorouracil can be increased when it is combined with Gemcitabine.
Ritonavir Ritonavir The metabolism of Fluorouracil can be decreased when combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Docetaxel.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Fluorouracil.
Zafirlukast Zafirlukast The metabolism of Fluorouracil can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Fluorouracil.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Fluorouracil.
Valsartan Valsartan The metabolism of Valsartan can be decreased when combined with Fluorouracil.
Insulin Lispro Injection Insulin Lispro Injection The metabolism of Fluorouracil can be increased when combined with Insulin lispro.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Fluorouracil.
Nelfinavir Nelfinavir Nelfinavir may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Azithromycin Azithromycin The metabolism of Fluorouracil can be decreased when combined with Azithromycin.
Loratadine Loratadine The metabolism of Fluorouracil can be decreased when combined with Loratadine.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Fluorouracil.
Nilutamide Nilutamide The metabolism of Fluorouracil can be decreased when combined with Nilutamide.
Flutamide Flutamide The metabolism of Fluorouracil can be decreased when combined with Flutamide.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Fluorouracil.
Sertraline Sertraline The metabolism of Sertraline can be decreased when combined with Fluorouracil.
Propafenone Propafenone The metabolism of Propafenone can be decreased when combined with Fluorouracil.
Letrozole Letrozole The metabolism of Fluorouracil can be decreased when combined with Letrozole.
Raloxifene Raloxifene The metabolism of Fluorouracil can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Fluorouracil can be decreased when combined with Irbesartan.
Quetiapine Quetiapine The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Quetiapine.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Fluorouracil.
Paroxetine Paroxetine The metabolism of Paroxetine can be decreased when combined with Fluorouracil.
Citalopram Citalopram The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Citalopram.
Capecitabine Capecitabine The metabolism of Capecitabine can be decreased when combined with Fluorouracil.
Efavirenz Efavirenz The metabolism of Fluorouracil can be decreased when combined with Efavirenz.
Sildenafil Sildenafil The metabolism of Sildenafil can be decreased when combined with Fluorouracil.
Pioglitazone Pioglitazone The metabolism of Fluorouracil can be decreased when combined with Pioglitazone.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Fluorouracil.
Celecoxib Celecoxib The metabolism of Fluorouracil can be decreased when combined with Celecoxib.
Rosiglitazone Rosiglitazone The metabolism of Fluorouracil can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Fluorouracil.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Fluorouracil is combined with Thalidomide.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Fluorouracil.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Fluorouracil.
Rabeprazole Rabeprazole The metabolism of Fluorouracil can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Fluorouracil.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists